{"ticker": {"uuid": "d2bff0fc-50d1-40bc-b930-c01ed07eab79", "symbol": "EQL", "name": "EQL Pharma AB", "exchange": "STO", "country": "SE", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "EQL Pharma Calls AGM, Proposes No Dividend and New Incentive Plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNVENRQnZaLXpLbkhTRXZRVll4SWdOYll3RnNZYlhCMkN1bDBwSGtfTzdVdlFXYU1wbDZEeDd5R0RSUmlmWWJKRWFNbkFFQXNBTVRUQ1Vha1BPbXoxM0tMR3NQaTdyUlZDRlRuSndZNTZ1aU5CVGx1ek9nRy1pVnJwZEluSUFrX2luSlVIaTNwQ1lsbl91WTZvUF9kRGdUaHhDZVZVNVFxbkZPRzVGUmNVUmV3QVprVWc?oc=5", "source_name": "TipRanks", "published_at": "2026-07-17T09:21:33+00:00", "published_display": "17 Jul 2026 09:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Notice of annual general meeting in EQL Pharma AB", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQb3ZULS10d25aRFhjbURZcUI3NTJKS1lJdktvZXUySEFMLXZxT3FNaDhUMWNGSHF2ODNuZFYxSHhzZjVIUHNGUk9nWlhZbDZRbWMwREdiSnE2X2hUWG81YTZNbG9ld3FTRWFkYjNJY0NraFJSV3h1RVVMLVNQOVpsbXhBTnlDNENqRjZvaHRKNUM?oc=5", "source_name": "TradeVenue", "published_at": "2026-07-17T08:33:56+00:00", "published_display": "17 Jul 2026 08:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EQL Pharma\u2019s Mellozzan Wins Approval in Kazakhstan, Extending Niche Generics Reach", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPb3NwUWp6by1JY0ZlOTVUYjhEbTR4d3pleF9oRTFMWVJIR2RxSm5Sa242aDdfNW5McGExREdhRFlmcF91dDhDVldfOURoWm5YWGZZSWlCRFg5azhpMXl3b3FlendQVGVOTk93RWZmbmI1Rk1LVVhaWGdKSFlWMmxJNWY0MkZ5cVo1akpzV2lGMjJqSHRKVm1oNy1CbjJScWJickZmNkphSGZ2VzNnNHhEVS1ici1ZMEhvbGhGSlNsYnNLWlpEWkt4WlVhOTc?oc=5", "source_name": "TipRanks", "published_at": "2026-07-15T08:47:48+00:00", "published_display": "15 Jul 2026 08:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EQL Pharma Sets August 7 Date for Q1 2026/27 Interim Report Presentation", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOT2JIVDd5dDRiVWtmNnRJOV9IUWZJWFB6Y0JsdUl6RGJZdHFNWWhsOWl1c3F6RVpSc1J2SEFEazZBNkxTd2U5SlhCRkYzdFFObS1NZ1RXbGh6bEt2RTNqT2V1d0llZlNfNllpODczUnpmR3ZTLTgxblhVVkM3YW9iQjFBZXdBVU1kZjdOQU5CSmxHMk4xUkRWZVBYX2lKUWN2NDhDMlYwZjZWQ3dlcFFuaTgyQU9PTlJ6b2ZUZnFGYjI4QQ?oc=5", "source_name": "TipRanks", "published_at": "2026-07-10T11:35:42+00:00", "published_display": "10 Jul 2026 11:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Analyst Just Downgraded Their EQL Pharma AB (publ) (STO:EQL) EPS Forecasts", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxOaDdLaWctZWdfaF9rMXR6SHlsVXdWTG5JYXkzeEdUaTBKZEk0MjBzMVV5SlRPQ3BETFRyZ0ZUR0Q4bTVvX3VfbXNheHlBOFIxZFVmZ1ZKbVdnZHMwWVBSZW13MWF3ZV8yQm9sNWVra0V4SFNWOWhRazB2RXVCZVZfWUJBcTRaMzJtdDZpQ1RaUVFNaVA3SVVSckN4Qy0yam5wVS1wWl9rUWxDMzY3UjBQdlRSMEsyYkxKWlRUazU1azUtWEJVOE9VUDFIYktPMm_SAdQBQVVfeXFMUHRmMlQydDRUVmp3RHFqSzM4SlRLREt6ZmxMQzQ2cFVqSlNtRHNxXzRrSEx5R0FyZzRnQjBtXzcydXZsR2dvclJHREZhbnlKZlFyclJGdERBeGg4UkZKSkNsdThmM25pdWN0S1ExZVZWbTg4Rjh0MlhCM1RmcVcxNnJGbWJ4eEJyUFVZemIzOGdFaFpURElkZU9aU0gyVzlaSVZtQ2UxejZMeVdtZjdlcFZfUDhRSHRLWlNEYlBXcUxfNzVHY3BnaDhueEhzQnhmNnpwV1Q?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EQL Pharma AB (publ) (STO:EQL) Shares Slammed 26% But Getting In Cheap Might Be Difficult Regardless", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-10-08T07:00:00+00:00", "published_display": "08 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "EQL Pharma Calls AGM, Proposes No Dividend and New Incentive Plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNVENRQnZaLXpLbkhTRXZRVll4SWdOYll3RnNZYlhCMkN1bDBwSGtfTzdVdlFXYU1wbDZEeDd5R0RSUmlmWWJKRWFNbkFFQXNBTVRUQ1Vha1BPbXoxM0tMR3NQaTdyUlZDRlRuSndZNTZ1aU5CVGx1ek9nRy1pVnJwZEluSUFrX2luSlVIaTNwQ1lsbl91WTZvUF9kRGdUaHhDZVZVNVFxbkZPRzVGUmNVUmV3QVprVWc?oc=5", "source_name": "TipRanks", "published_at": "2026-07-17T09:21:33+00:00", "published_display": "17 Jul 2026 09:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Notice of annual general meeting in EQL Pharma AB", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQb3ZULS10d25aRFhjbURZcUI3NTJKS1lJdktvZXUySEFMLXZxT3FNaDhUMWNGSHF2ODNuZFYxSHhzZjVIUHNGUk9nWlhZbDZRbWMwREdiSnE2X2hUWG81YTZNbG9ld3FTRWFkYjNJY0NraFJSV3h1RVVMLVNQOVpsbXhBTnlDNENqRjZvaHRKNUM?oc=5", "source_name": "TradeVenue", "published_at": "2026-07-17T08:33:56+00:00", "published_display": "17 Jul 2026 08:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EQL Pharma\u2019s Mellozzan Wins Approval in Kazakhstan, Extending Niche Generics Reach", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPb3NwUWp6by1JY0ZlOTVUYjhEbTR4d3pleF9oRTFMWVJIR2RxSm5Sa242aDdfNW5McGExREdhRFlmcF91dDhDVldfOURoWm5YWGZZSWlCRFg5azhpMXl3b3FlendQVGVOTk93RWZmbmI1Rk1LVVhaWGdKSFlWMmxJNWY0MkZ5cVo1akpzV2lGMjJqSHRKVm1oNy1CbjJScWJickZmNkphSGZ2VzNnNHhEVS1ici1ZMEhvbGhGSlNsYnNLWlpEWkt4WlVhOTc?oc=5", "source_name": "TipRanks", "published_at": "2026-07-15T08:47:48+00:00", "published_display": "15 Jul 2026 08:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EQL Pharma Sets August 7 Date for Q1 2026/27 Interim Report Presentation", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOT2JIVDd5dDRiVWtmNnRJOV9IUWZJWFB6Y0JsdUl6RGJZdHFNWWhsOWl1c3F6RVpSc1J2SEFEazZBNkxTd2U5SlhCRkYzdFFObS1NZ1RXbGh6bEt2RTNqT2V1d0llZlNfNllpODczUnpmR3ZTLTgxblhVVkM3YW9iQjFBZXdBVU1kZjdOQU5CSmxHMk4xUkRWZVBYX2lKUWN2NDhDMlYwZjZWQ3dlcFFuaTgyQU9PTlJ6b2ZUZnFGYjI4QQ?oc=5", "source_name": "TipRanks", "published_at": "2026-07-10T11:35:42+00:00", "published_display": "10 Jul 2026 11:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Analyst Just Downgraded Their EQL Pharma AB (publ) (STO:EQL) EPS Forecasts", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxOaDdLaWctZWdfaF9rMXR6SHlsVXdWTG5JYXkzeEdUaTBKZEk0MjBzMVV5SlRPQ3BETFRyZ0ZUR0Q4bTVvX3VfbXNheHlBOFIxZFVmZ1ZKbVdnZHMwWVBSZW13MWF3ZV8yQm9sNWVra0V4SFNWOWhRazB2RXVCZVZfWUJBcTRaMzJtdDZpQ1RaUVFNaVA3SVVSckN4Qy0yam5wVS1wWl9rUWxDMzY3UjBQdlRSMEsyYkxKWlRUazU1azUtWEJVOE9VUDFIYktPMm_SAdQBQVVfeXFMUHRmMlQydDRUVmp3RHFqSzM4SlRLREt6ZmxMQzQ2cFVqSlNtRHNxXzRrSEx5R0FyZzRnQjBtXzcydXZsR2dvclJHREZhbnlKZlFyclJGdERBeGg4UkZKSkNsdThmM25pdWN0S1ExZVZWbTg4Rjh0MlhCM1RmcVcxNnJGbWJ4eEJyUFVZemIzOGdFaFpURElkZU9aU0gyVzlaSVZtQ2UxejZMeVdtZjdlcFZfUDhRSHRLWlNEYlBXcUxfNzVHY3BnaDhueEhzQnhmNnpwV1Q?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EQL Pharma AB (publ) (STO:EQL) Shares Slammed 26% But Getting In Cheap Might Be Difficult Regardless", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-10-08T07:00:00+00:00", "published_display": "08 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 57, "total_relevant": 6, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 6, "score": 50, "total": 6, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 68, "events": [{"event": "general", "label": "Market update", "weight": 1.65, "count": 3}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 23.35, "latest_week": "2026-07-10", "one_week_move": -2.1, "four_week_move": -4.9, "twelve_week_move": -59.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.103301, "market_dynamics_buy_signal": false, "relative_strength": -63.025973, "fair_value_gap": -63.7, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 42.3224, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.1% over one week, -4.9% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 54, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TipRanks", "count": 3}, {"label": "simplywall.st", "count": 2}, {"label": "TradeVenue", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 6}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}, {"label": "Capital return", "count": 1}, {"label": "Regulatory and legal", "count": 1}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "68/100 classification confidence."}, {"label": "Company focus", "value": "6", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-2.1% over one week, -4.9% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "EQL Pharma Calls AGM, Proposes No Dividend and New Incentive Plan"}], "updated_at": "2026-07-18T13:41:06.781596+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}